TABLE 50First year direct treatment costs of first stroke in patients with SCD

Post-stroke stateTotal one-off 3-monthly costs (£)Ongoing 3-month costs (£)Total first post-stroke year cost (£)Prevalence of first stroke outcomes (%)Weighted average cost of first stroke in year 1 (£)
Mild37373274718211000
Moderate8161164913,108405283
Severe18,417661738,2683312,628
DeadNANANA60
Weighted average cost of first stroke across all age groups18,862

NA, not applicable.

From: Appendix 4, Data used in the cost-effectiveness analysis

Cover of The Clinical Effectiveness and Cost-Effectiveness of Primary Stroke Prevention in Children with Sickle Cell Disease: A Systematic Review and Economic Evaluation
The Clinical Effectiveness and Cost-Effectiveness of Primary Stroke Prevention in Children with Sickle Cell Disease: A Systematic Review and Economic Evaluation.
Health Technology Assessment, No. 16.43.
Cherry MG, Greenhalgh J, Osipenko L, et al.
Southampton (UK): NIHR Journals Library; 2012 Nov.
© 2012, Crown Copyright.

Included under terms of UK Non-commercial Government License.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.